The Division of Cardiothoracic Surgery is committed to fulfilling Stony Brook’s mission of excellence in research, and to advancing scientific knowledge to improve patient care and population health.
Participation in our clinical trials is always completely voluntary, and never interferes with the normal standards for patient care.
Our clinical trials enable us to use, in addition to established therapies, the newest and most advanced technologies and treatments — long before they are available to other physicians.
Our clinical trials include a range of new strategies to improve the outcomes of heart surgery and also the technology used by surgeons.
Evaluations of newly developed drug therapies to improve surgical outcomes are conducted, as well.
Patients participate in our clinical trials only after they receive a complete explanation of their options from their surgeon and surgical team.
For information about our current clinical trials, please visit our Clinical Trials page, or call our clinical research coordinator Jeannine Molzon, LPN, at 631-444-8156.